PEDT-03 A clinical trial of dendritic cell-based immunotherapy for refractory brain tumors in children

Background/Objectives: Relapse or refractory brain tumor in childhood continue to have a dismal prognosis in spite of developing multidisciplinary treatment. Cancer immunotherapy is newly expected as next promising treatment for highly aggressive pediatric cancer. This trial was designed to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Akasaki, Yasuharu, Yamaoka, Masayoshi, Takei, Jun, Nonaka, Yuichirou, Hirotsu, Tatsuya, Akiyama, Masaharu, Yanagisawa, Takaaki, Ohashi, Touya, Ida, Hiroyuki, Murayama, Yuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699127/
http://dx.doi.org/10.1093/noajnl/vdaa143.038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699127/
http://dx.doi.org/10.1093/noajnl/vdaa143.038

Ejemplares similares